Periodic Reporting for period 1 - EASI-Genomics (European Advanced infraStructure for Innovative Genomics)
Reporting period: 2019-02-01 to 2020-07-31
In the context of the generalization of genomics in healthcare and the imminent advent of personalized/precision medicine in Europe, the scientific community will tremendously benefit from leveraging the expertise and capacity of national genomics facilities. Access to the latest genomics technologies and analytical expertise will certainly accelerate scientific discoveries and improve the competitiveness of the research community.
The mission of EASI-Genomics is to provide easy and seamless access to cutting-edge DNA sequencing technologies to researchers from academia and industry covering the entire experimental cycle from study design to the interpretation of results. To achieve this goal, 11 state-of-the-art European genomics platforms regularly organise calls for proposals to offer transnational access to the research community and provide comprehensive support to access projects. Moreover, altogether the 16 partners of EASI-Genomics collaborate on research and networking activities to define new genomics standards, develop and integrate new laboratory and computational methodologies and develop a framework for ensuring ethical, legal, and societal highest standards. Eventually, EASI-Genomics is developing a powerful collaborative European infrastructure in genomics available to the research and industry community.